Abstract:Colorectal cancer is the third most common cancer worldwide with abysmal survival, thus requiring novel therapy strategies. Numerous studies have frequently observed infiltrating bacteria within the primary tumor tissues derived from patients. These studies have implicated the relative abundance of these bacteria as a contributing factor in tumor progression. Infiltrating bacteria are believed to be among the major drivers of tumorigenesis, progression, and metastasis and, hence, promising targets for new treatments. However, measuring their abundance directly remains challenging. One potential approach is to use the unmapped reads of host whole genome sequencing (hWGS) data, which previous studies have considered as contaminants and discarded. Here, we developed rigorous bioinformatics and statistical procedures to identify tumor-infiltrating bacteria associated with colorectal cancer from such whole genome sequencing data. Our approach used the reads of whole genome sequencing data of colon adenocarcinoma tissues not mapped to the human reference genome, including unmapped paired-end read pairs and single-end reads, the mates of which were mapped. We assembled the unmapped read pairs, remapped all those reads to the collection of human microbiome reference, and then computed their relative abundance of microbes by maximum likelihood (ML) estimation. We analyzed and compared the relative abundance and diversity of infiltrating bacteria between primary tumor tissues and associated normal blood samples. Our results showed that primary tumor tissues contained far more diverse total infiltrating bacteria than normal blood samples. The relative abundance of Bacteroides fragilis, Bacteroides dorei, and Fusobacterium nucleatum was significantly higher in primary colorectal tumors. These three bacteria were among the top ten microbes in the primary tumor tissues, yet were rarely found in normal blood samples. As a validation step, most of these bacteria were also closely associated with colorectal cancer in previous studies with alternative approaches. In summary, our approach provides a new analytic technique for investigating the infiltrating bacterial community within tumor tissues. Our novel cloud-based bioinformatics and statistical pipelines to analyze the infiltrating bacteria in colorectal tumors using the unmapped reads of whole genome sequences can be freely accessed from GitHub at https://github.com/gutmicrobes/UMIB.git.

Sequence-Based Characterization of Intratumoral Bacteria—A Guide to Best Practice

Intratumoral Microbiota as a Target for Advanced Cancer Therapeutics

Intratumoural microbiota: from theory to clinical application

Awareness of intratumoral bacteria and their potential application in cancer treatment

Intracellular bacteria in cancer—prospects and debates

Emerging roles of intratumor microbiota in cancer: tumorigenesis and management strategies

Broadening oncological boundaries: the intratumoral microbiota

Global Analysis of Microbiota Signatures in Four Major Types of Gastrointestinal Cancer

Intratumoral Bacteria Are an Important “accomplice” in Tumor Development and Metastasis

Progress of Tumor-Resident Intracellular Bacteria for Cancer Therapy

Current understanding of the intratumoral microbiome in various tumors

Exogenous Sequences in Tumors and Immune Cells (Exotic): A Tool for Estimating the Microbe Abundances in Tumor RNA-seq Data

Microbiota in Tumors: from Understanding to Application

Unveiling the intratumoral microbiota within cancer landscapes

Potential role of intratumor bacteria outside the gastrointestinal tract: More than passengers

Intratumoral Microbiome and Gastrointestinal Cancers

Intratumoral microbiota in colorectal cancer: focus on specific distribution and potential mechanisms

The Emerging Tumor Microbe Microenvironment: from Delineation to Multidisciplinary Approach-Based Interventions

Inferring Bacterial Infiltration in Primary Colorectal Tumors from Host Whole Genome Sequencing Data

Relevance of harmful intratumoral microbiota in cancer progression and its clinical application

Intratumoral Microbiota: Metabolic Influences and Biomarker Potential in Gastrointestinal Cancer